# Michael A. Allon, MPPA – FDA 483, Jun 1, 2026

Source: https://www.keypedia.com/records/483/michael-a-allon-mppa/8e215ff1-4956-4d0c-b7fa-6869c82ea4f2

> FDA 483 for Michael A. Allon, MPPA on June 01, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Michael A. Allon, MPPA
- Inspection Date: 2026-06-01
- Product Type: other
- Office Name: Dallas District Office
- Summary: Michael A. Allon, M.D, P.A. in Houston, TX, a reproductive tissue establishment, was cited for significant deficiencies in donor screening and eligibility determination for HCT/P donors. The inspection revealed failures to adequately screen donors for communicable disease risk factors, maintain complete and accurate donor records, and establish compliant procedures for donor eligibility and record-keeping. These issues indicate a systemic lack of control over critical processes for ensuring donor safety.

## Related Officers

- [Elyshia Q. Danaher](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)
- [Ashleigh M. Robertson](https://www.keypedia.com/people/ashleigh-m-robertson/b9f909fe-54cf-42c8-82cd-0fcb7b76e78c)

Company: https://www.keypedia.com/companies/michael-a-allon-mppa/eb66005d-54b3-44b0-b703-1115f6d3811c

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9